Introduction
Mpox is usually diagnosed by combining clinical suspicion with laboratory confirmation. Because the illness can resemble other viral skin infections or sexually transmitted infections, especially in its early stages, doctors do not rely on appearance alone. The diagnosis matters because it helps guide isolation decisions, symptom management, contact tracing, and public health reporting. It also helps distinguish Mpox from conditions that may require different treatment or carry different risks.
Mpox is caused by an orthopoxvirus that infects skin and mucosal tissues, then produces local inflammation and viral replication that often leads to characteristic lesions. Since the pattern of spread and the skin findings can vary from person to person, accurate diagnosis depends on understanding both the clinical picture and the appropriate tests.
Recognizing Possible Signs of the Condition
Medical professionals often suspect Mpox when a patient develops a rash with lesions that progress through a fairly recognizable sequence. The lesions may begin as flat spots, then become raised bumps, fluid-filled blisters, and eventually pustules before crusting over. In many cases, the lesions are firm or deep-seated rather than superficial, and they may be painful or tender.
Symptoms that raise suspicion include fever, swollen lymph nodes, fatigue, headache, muscle aches, and chills. Lymph node enlargement is especially important because it helps distinguish Mpox from some other illnesses that can produce similar rashes. The rash may involve the face, trunk, hands, feet, genitals, anus, or mouth, and sometimes the lesions are concentrated at one site of inoculation rather than widely distributed.
Doctors also consider the timing of symptom progression. Mpox often causes a sequence in which systemic symptoms appear before or around the time of rash, although current outbreaks have shown that some patients notice lesions first or have minimal prodromal symptoms. Rectal pain, sore throat, painful swallowing, or lesions in the mouth or genital region may also prompt further evaluation, especially when there has been close contact with an infected person or exposure in a setting with known transmission.
Medical History and Physical Examination
The diagnostic process begins with a careful history. Clinicians ask when symptoms started, how the rash has changed over time, whether there was fever or lymph node swelling, and whether any lesions are painful or itchy. They also ask about recent close physical contact, sexual exposure, travel, attendance at events with close skin-to-skin contact, household exposure, animal contact, and known exposure to someone with Mpox.
Medical history is important because risk factors can change the level of suspicion. A person who has had direct contact with a case, slept in the same bed as an infected individual, or shared bedding or clothing may be more likely to have Mpox than someone with no obvious exposure history. Clinicians also review vaccination history, immune status, pregnancy status, and prior skin conditions because these may influence both the likelihood of infection and the appearance of the rash.
During the physical examination, healthcare professionals inspect the skin and mucous membranes carefully. They note the number, location, stage, and shape of the lesions. They look for whether lesions are all in the same stage or at different stages of evolution, whether they are umbilicated, whether they are clustered or scattered, and whether there is surrounding redness or secondary bacterial infection. The presence of lymphadenopathy, especially cervical, axillary, or inguinal enlargement, provides additional diagnostic support.
The exam may also include checking the mouth, throat, anus, genital area, and palms and soles, because Mpox can affect these regions. If a patient has rectal pain, tenesmus, or discharge, clinicians may consider proctitis and examine for associated lesions. In severe cases or in people with weakened immune systems, the exam may reveal widespread lesions, extensive swelling, or signs of complications that need urgent attention.
Diagnostic Tests Used for Mpox
The primary test used to confirm Mpox is laboratory-based detection of viral DNA by polymerase chain reaction, or PCR. Samples are usually taken from the surface of skin lesions, including swabs of the lesion roof or base, fluid from pustules or vesicles, or crust material. PCR detects viral genetic material and is highly sensitive when the specimen is collected properly. Because lesions contain the highest amount of virus, lesion sampling is preferred over blood testing in most cases.
Laboratory testing may also include ruling out other infections. Depending on the presentation, clinicians may order tests for herpes simplex virus, varicella-zoster virus, syphilis, gonorrhea, chlamydia, or HIV. These tests are not used to confirm Mpox itself, but they help identify or exclude other causes of rash, ulcers, or genital lesions that can look similar.
Blood tests are sometimes used to assess overall health rather than to diagnose Mpox directly. A complete blood count may show inflammation or other clues to infection, and basic metabolic tests can help evaluate dehydration, organ involvement, or complications. In severe cases or when hospitalization is needed, these studies support clinical management and help identify complications, but they are not the definitive test for Mpox.
Imaging tests are not usually required to diagnose uncomplicated Mpox. However, if a patient has symptoms suggesting deeper involvement, imaging may be useful. For example, ultrasound, computed tomography, or other imaging can help evaluate swollen lymph nodes, abscess-like lesions, or complications in areas such as the abdomen, throat, or rectum. Imaging does not confirm the virus itself, but it may clarify whether symptoms reflect inflammation, secondary infection, or an alternate diagnosis.
Functional tests are also not part of routine Mpox diagnosis, but clinicians may use symptom-based assessments to evaluate how the disease is affecting the patient. For instance, if lesions interfere with swallowing, urination, or bowel movements, the medical team may assess those functions directly. In severe disease, respiratory or neurologic evaluation may be needed if complications are suspected. These assessments help determine the extent of illness rather than identify the virus.
Tissue examination is rarely needed, but in uncertain cases a biopsy may be performed. Histopathology can show viral cytopathic changes and inflammation, and special staining or molecular methods may detect orthopoxviral infection in tissue. Biopsy is generally reserved for atypical cases, unclear rashes, or situations where cancer, inflammatory disease, or another dermatologic condition is being considered. Because lesion PCR is usually sufficient, tissue examination is not a first-line diagnostic method.
Interpreting Diagnostic Results
A positive PCR result from a lesion sample generally confirms Mpox when the clinical picture is compatible. Because PCR detects viral DNA, it indicates that the virus is present in the sampled lesion. The reliability of the result depends on good specimen collection, correct lesion selection, and appropriate laboratory handling. Multiple lesions may be sampled if the diagnosis is uncertain or if the first specimen is inadequate.
A negative test does not always rule out Mpox if the sample was taken too early, from a poorly chosen site, or from a lesion that no longer contains much virus. In that setting, clinicians may repeat testing from a fresher lesion or a different lesion stage. The interpretation also depends on whether another diagnosis better explains the symptoms. If clinical suspicion remains high, doctors often continue isolation and evaluate other possibilities while awaiting repeat testing or additional laboratory results.
Doctors interpret results in the context of disease timing, exposure history, and lesion morphology. A person with typical lesions and a positive PCR is usually diagnosed with confidence. A person with atypical lesions, no known exposure, and a negative PCR may be more likely to have another condition. When test results and clinical findings do not match neatly, the diagnostic approach may expand to include additional infectious, dermatologic, or inflammatory causes.
Conditions That May Need to Be Distinguished
Several conditions can resemble Mpox, especially early in the illness. Herpes simplex infection can cause painful grouped vesicles or ulcers, particularly in the genital or oral region. Varicella-zoster virus can produce vesicular lesions that appear in crops, and chickenpox may be confused with Mpox if the rash is widespread. Syphilis, especially secondary or early lesions, may also enter the differential diagnosis in patients with mucocutaneous findings.
Bacterial skin infections such as impetigo, folliculitis, or abscesses may look similar when lesions are crusted or inflamed. Allergic or drug-related eruptions can produce widespread rashes, though they usually lack the characteristic lesion evolution and lymph node swelling seen in Mpox. Hand-foot-and-mouth disease, molluscum contagiosum, scabies, and certain fungal infections may also be considered depending on the appearance and distribution of the lesions.
Doctors differentiate these conditions by combining exposure history, lesion pattern, symptom sequence, and laboratory testing. Mpox often has firm, deep lesions that evolve in a synchronized way within a region, along with lymphadenopathy and a compatible exposure history. PCR testing from lesions usually resolves uncertainty, and additional tests for herpes, syphilis, or other pathogens may be used when coinfection or an alternate diagnosis is possible.
Factors That Influence Diagnosis
Several factors can affect how Mpox is diagnosed. Disease severity is one of the most important. Patients with mild illness may have only a few lesions and limited systemic symptoms, which can make clinical recognition more difficult. By contrast, severe disease can involve numerous lesions, extensive mucosal involvement, dehydration, or secondary bacterial infection, all of which may require broader evaluation.
Age also matters. Children can present differently from adults, and in infants or young children clinicians may need to be especially careful because the rash may resemble common pediatric infections. Older adults or people with weakened immune systems may have more extensive disease or atypical findings. Immunocompromised patients can develop prolonged illness, unusual lesion patterns, or higher risk of complications, which may increase the need for additional testing and close monitoring.
Related medical conditions can also influence the diagnostic process. People with eczema or other chronic skin disorders may have lesions that are harder to interpret visually. Pregnancy can change the threshold for testing and monitoring because of concerns about maternal and fetal health. Coexisting sexually transmitted infections, HIV infection, or recent antiviral use may affect both the differential diagnosis and the interpretation of symptoms. In some settings, public health guidance also shapes how quickly testing is done and which contacts are evaluated.
Conclusion
Mpox is diagnosed through a combination of clinical assessment and laboratory confirmation. The process begins with recognizing a compatible rash, systemic symptoms, and possible exposure history, then proceeds to careful physical examination and targeted testing. PCR testing of lesion material is the main confirmatory method, while other tests help exclude similar infections or assess complications. Imaging, functional evaluation, and tissue examination are used selectively when the presentation is unclear or severe.
Accurate diagnosis depends on matching test results with the biological behavior of the infection and the pattern of lesions it produces. By combining symptom review, examination, and laboratory evidence, clinicians can identify Mpox reliably and distinguish it from other conditions that may look similar.